Prioritized Current Unmet Needs for Antibacterial Therapies

The FDA Reboot of Antibiotic Development

(2013) David M. Shlaes et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Seven Ways to Preserve the Miracle of Antibiotics

(2013) J. G. Bartlett et al.   CLINICAL INFECTIOUS DISEASES

The value of single-pathogen antibacterial agents

(2013) Brad Spellberg et al.   NATURE REVIEWS DRUG DISCOVERY

The Future of Antibiotics and Resistance

(2013) Brad Spellberg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Unmet Medical Need in Infectious Diseases

(2012) A. L. Hersh et al.   CLINICAL INFECTIOUS DISEASES

White Paper: Recommendations on the Conduct of Superiority and Organism-Specific Clinical Trials of Antibacterial Agents for the Treatment of Infections Caused by Drug-Resistant Bacterial Pathogens

(2012)   CLINICAL INFECTIOUS DISEASES

Community-Associated Extended-Spectrum β-Lactamase–Producing Escherichia coli Infection in the United States

(2012) Yohei Doi et al.   CLINICAL INFECTIOUS DISEASES

Overcoming the challenges to developing new antibiotics

(2012) David M Shlaes et al.   CURRENT OPINION IN PHARMACOLOGY

International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases

(2011) Kalpana Gupta et al.   CLINICAL INFECTIOUS DISEASES

Risk Factors and Outcomes Associated with Acquisition of Colistin-Resistant KPC-Producing Klebsiella pneumoniae: a Matched Case-Control Study

(2010) O. Zarkotou et al.   JOURNAL OF CLINICAL MICROBIOLOGY